|
1
|
Wang J, Yang H, Si Y, Hu D, Yu Y, Zhang Y,
Gao M and Zhang H: Iodine promotes tumorigenesis of thyroid cancer
by suppressing Mir-422a and up-regulating MAPK1. Cell Physiol
Biochem. 43:1325–1336. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kaptan E, Sancar-Bas S, Sancakli A, Bektas
S and Bolkent S: The effect of plant lectins on the survival and
malignant behaviors of thyroid cancer cells. J Cell Biochem.
119:6274–6287. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sokić SI, Adanja BJ, Vlajinac HD, Janković
RR, Marinković JP and Zivaljević VR: Risk factors for thyroid
cancer. Neoplasma. 41:371–374. 1994.PubMed/NCBI
|
|
4
|
Takacsova E, Kralik R, Waczulikova I,
Zavodna K and Kausitz J: A different prognostic value of BRAFV600E
mutation positivity in various age groups of patients with
papillary thyroid cancer. Neoplasma. 64:156–164. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Di W, Li Q, Shen W, Guo H and Zhao S: The
long non-coding RNA HOTAIR promotes thyroid cancer cell growth,
invasion and migration through the miR-1-CCND2 axis. Am J Cancer
Res. 7:1298–1309. 2017.PubMed/NCBI
|
|
6
|
Xing M, Haugen BR and Schlumberger M:
Progress in molecular-based management of differentiated thyroid
cancer. Lancet. 381:1058–1069. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ding ZY, Huang YJ, Tang JD, Li G, Jiang PQ
and Wu HT: Silencing of hypoxia-inducible factor-1α promotes
thyroid cancer cell apoptosis and inhibits invasion by
downregulating WWP2, WWP9, VEGF and VEGFR2. Exp Ther Med.
12:3735–3741. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lim ST, Jeon YW and Suh YJ: The prognostic
values of preoperative tumor volume and tumor diameter in T1N0
papillary thyroid cancer. Cancer Res Treat. 49:890–897. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rachinsky I, Rajaraman M, Leslie WD,
Zahedi A, Jefford C, McGibbon A, Young JE, Pathak KA, Badreddine M,
De Brabandere S, et al: Regional variation across Canadian centers
in radioiodine administration for thyroid remnant ablation in
well-differentiated thyroid cancer diagnosed in 2000–2010. J
Thyroid Res. 2016:28679162016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guan H, Liang W, Xie Z, Li H, Liu J, Liu
L, Xiu L and Li Y: Down-regulation of miR-144 promotes thyroid
cancer cell invasion by targeting ZEB1 and ZEB2. Endocrine.
48:566–574. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vasko VV and Saji M: Molecular mechanisms
involved in differentiated thyroid cancer invasion and metastasis.
Curr Opin Oncol. 19:11–17. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liao T, Wang YJ, Hu JQ, Wang Y, Han LT, Ma
B, Shi RL, Qu N, Wei WJ, Guan Q, et al: Histone methyltransferase
KMT5A gene modulates oncogenesis and lipid metabolism of papillary
thyroid cancer in vitro. Oncol Rep. 39:2185–2192.
2018.PubMed/NCBI
|
|
13
|
Lu ZL, Chen YJ, Jing XY, Wang NN, Zhang T
and Hu CJ: Detection and identification of serum peptides biomarker
in papillary thyroid cancer. Med Sci Monit. 24:1581–1587. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhao W, Chen S, Hou X, Chen G and Zhao Y:
CHK2 promotes anoikis and is associated with the progression of
papillary thyroid cancer. Cell Physiol Biochem. 45:1590–1602. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shi Z, Zhou H, Lu L, Li X, Fu Z, Liu J,
Kang Y, Wei Z, Pan B, Liu L, et al: The roles of microRNAs in
spinal cord injury. Int J Neurosci. 127:1104–1115. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ouyang Q, Xu L, Cui H, Xu M and Yi L:
MicroRNAs and cell cycle of malignant glioma. Int J Neurosci.
126:1–9. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo J, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: A novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang RJ, Zheng YH, Wang P and Zhang JZ:
Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in
non-small cell lung cancer. Int J Clin Exp Pathol. 8:765–771.
2015.PubMed/NCBI
|
|
19
|
Fuziwara CS and Kimura ET: MicroRNA
deregulation in anaplastic thyroid cancer biology. Int J
Endocrinol. 2014:7434502014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Costa-Pinheiro P, Ramalho-Carvalho J,
Vieira FQ, Torres-Ferreira J, Oliveira J, Gonçalves CS, Costa BM,
Henrique R and Jerónimo C: MicroRNA-375 plays a dual role in
prostate carcinogenesis. Clin Epigenetics. 7:422015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xing M: Molecular pathogenesis and
mechanisms of thyroid cancer. Nat Rev Cancer. 13:184–199. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Perros P, Boelaert K, Colley S, Evans C,
Evans RM, Gerrard Ba G, Gilbert J, Harrison B, Johnson SJ, Giles
TE, et al: Guidelines for the management of thyroid cancer. Clin
Endocrinol (Oxf). 81 (Suppl 1):S1–S122. 2014. View Article : Google Scholar
|
|
24
|
Bi CL, Zhang YQ, Li B, Guo M and Fu YL:
MicroRNA-520a-3p suppresses epithelial-mesenchymal transition,
invasion, and migration of papillary thyroid carcinoma cells via
the JAK1-mediated JAK/STAT signaling pathway. J Cell Physiol.
234:4054–4067. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu H, Guo J, Chai H and Meng X:
MicroRNA-744 suppresses cell proliferation and invasion of
papillary thyroid cancer by directly targeting NOB1. Mol Med Rep.
19:1903–1910. 2019.PubMed/NCBI
|
|
26
|
Heidari Z, Mohammadpour-Gharehbagh A,
Eskandari M, Harati-Sadegh M and Salimi S: Genetic polymorphisms of
miRNA let7a-2 and pri-mir-34b/c are associated with an increased
risk of papillary thyroid carcinoma and clinical/pathological
features. J Cell Biochem. 14–Dec;2018.(Epub ahead of print).
|
|
27
|
Damodaran M, Paul SFD and Venkatesan V:
Genetic polymorphisms in miR-146a, miR-196a2 and miR-125a genes and
its association in prostate cancer. Pathol Oncol Res.
29–Mar;2018.(Epub ahead of print). View Article : Google Scholar
|
|
28
|
Mo JS, Park YR and Chae SC: MicroRNA 196B
regulates HOXA5, HOXB6 and GLTP expression levels in colorectal
cancer cells. Pathol Oncol Res. 12–Mar;2018.(Epub ahead of print).
View Article : Google Scholar
|
|
29
|
Seclaman E, Narita D, Anghel A, Cireap N,
Ilina R, Sirbu IO and Marian C: MicroRNA expression in laser
micro-dissected breast cancer tissue samples-a pilot study. Pathol
Oncol Res. 25:233–239. 2019. View Article : Google Scholar
|
|
30
|
Yue K, Wang X, Wu Y, Zhou X, He Q and Duan
Y: microRNA-7 regulates cell growth, migration and invasion via
direct targeting of PAK1 in thyroid cancer. Mol Med Rep.
14:2127–2134. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dong S, Meng X, Xue S, Yan Z, Ren P and
Liu J: microRNA-141 inhibits thyroid cancer cell growth and
metastasis by targeting insulin receptor substrate 2. Am J Transl
Res. 8:1471–1481. 2016.PubMed/NCBI
|
|
32
|
Wang P, Meng X, Huang Y, Lv Z, Liu J, Wang
G, Meng W, Xue S, Zhang Q, Zhang P and Chen G: MicroRNA-497
inhibits thyroid cancer tumor growth and invasion by suppressing
BDNF. Oncotarget. 8:2825–2834. 2017.PubMed/NCBI
|
|
33
|
Westendorp B, Mokry M, Groot Koerkamp MJ,
Holstege FC, Cuppen E and de Bruin A: E2F7 represses a network of
oscillating cell cycle genes to control S-phase progression.
Nucleic Acids Res. 40:3511–3523. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen D, Pacal M, Wenzel P, Knoepfler PS,
Leone G and Bremner R: Division and apoptosis of E2f-deficient
retinal progenitors. Nature. 462:925–929. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mitxelena J, Apraiz A, Vallejo-Rodríguez
J, García-Santisteban I, Fullaondo A, Alvarez-Fernández M,
Malumbres M and Zubiaga AM: An E2F7-dependent transcriptional
program modulates DNA damage repair and genomic stability. Nucleic
Acids Res. 46:4546–4559. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Carvajal LA, Hamard PJ, Tonnessen C and
Manfredi JJ: E2F7, a novel target, is up-regulated by p53 and
mediates DNA damage-dependent transcriptional repression. Genes
Dev. 26:1533–1545. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yin W, Wang B, Ding M, Huo Y, Hu H, Cai R,
Zhou T, Gao Z, Wang Z and Chen D: Elevated E2F7 expression predicts
poor prognosis in human patients with gliomas. J Clin Neurosci.
33:187–193. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ye YY, Mei JW, Xiang SS, Li HF, Ma Q, Song
XL, Wang Z, Zhang YC, Liu YC, Jin YP, et al: MicroRNA-30a-5p
inhibits gallbladder cancer cell proliferation, migration and
metastasis by targeting E2F7. Cell Death Dis. 9:4102018. View Article : Google Scholar : PubMed/NCBI
|
